128 related articles for article (PubMed ID: 38432004)
1. An ATPase-Mimicking MXene nanozyme pharmacologically breaks the ironclad defense system for ferroptosis cancer therapy.
Wang H; Liu X; Yan X; Du Y; Pu F; Ren J; Qu X
Biomaterials; 2024 Jun; 307():122523. PubMed ID: 38432004
[TBL] [Abstract][Full Text] [Related]
2. Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis.
Anandhan A; Dodson M; Schmidlin CJ; Liu P; Zhang DD
Cell Chem Biol; 2020 Apr; 27(4):436-447. PubMed ID: 32275864
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis.
Wang Z; Li R; Hou N; Zhang J; Wang T; Fan P; Ji C; Zhang B; Liu L; Wang Y; Kong J; Yao Q; Duan J; Zhao G; Ling R; Zhang J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37380368
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy
Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X
Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601
[No Abstract] [Full Text] [Related]
5. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.
Zhou TJ; Zhang MM; Liu DM; Huang LL; Yu HQ; Wang Y; Xing L; Jiang HL
Biomaterials; 2024 Mar; 305():122447. PubMed ID: 38154441
[TBL] [Abstract][Full Text] [Related]
6. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
[TBL] [Abstract][Full Text] [Related]
7. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer.
Takatani-Nakase T; Ikushima C; Sakitani M; Nakase I
Life Sci; 2024 Feb; 339():122411. PubMed ID: 38184272
[TBL] [Abstract][Full Text] [Related]
8. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
[TBL] [Abstract][Full Text] [Related]
9. High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Meng X; Li D; Chen L; He H; Wang Q; Hong C; He J; Gao X; Yang Y; Jiang B; Nie G; Yan X; Gao L; Fan K
ACS Nano; 2021 Mar; 15(3):5735-5751. PubMed ID: 33705663
[TBL] [Abstract][Full Text] [Related]
10. Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer.
Lee J; Roh JL
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166788. PubMed ID: 37302427
[TBL] [Abstract][Full Text] [Related]
11. Architecture of Vanadium-Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy.
Zhao R; Zhu Y; Feng L; Liu B; Hu Y; Zhu H; Zhao Z; Ding H; Gai S; Yang P
Adv Mater; 2024 Jan; 36(2):e2307115. PubMed ID: 37732568
[TBL] [Abstract][Full Text] [Related]
12. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis.
Dodson M; Castro-Portuguez R; Zhang DD
Redox Biol; 2019 May; 23():101107. PubMed ID: 30692038
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis: The functions of Nrf2 in human embryonic stem cells.
Babaei-Abraki S; Karamali F; Nasr-Esfahani MH
Cell Signal; 2023 Jun; 106():110654. PubMed ID: 36906163
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
15. Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis.
Liu Z; Lv X; Song E; Song Y
Toxicol Appl Pharmacol; 2020 Nov; 407():115241. PubMed ID: 32937103
[TBL] [Abstract][Full Text] [Related]
16. Tiliroside induces ferroptosis to repress the development of triple-negative breast cancer cells.
Hu C; Zhao JF; Wang YM; Wu XL; Ye L
Tissue Cell; 2023 Aug; 83():102116. PubMed ID: 37301139
[TBL] [Abstract][Full Text] [Related]
17. NIR Plasmonic Nanozymes: Synergistic Enhancement Mechanism and Multi-Modal Anti-Infection Applications of MXene/MOFs.
Zhao X; Chen Y; Niu R; Tang Y; Chen Y; Su H; Yang Z; Jing X; Guan H; Gao R; Meng L
Adv Mater; 2024 Feb; 36(8):e2307839. PubMed ID: 37812814
[TBL] [Abstract][Full Text] [Related]
18. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
19. Melatonin inhibits ferroptosis and delays age-related cataract by regulating SIRT6/p-Nrf2/GPX4 and SIRT6/NCOA4/FTH1 pathways.
Mi Y; Wei C; Sun L; Liu H; Zhang J; Luo J; Yu X; He J; Ge H; Liu P
Biomed Pharmacother; 2023 Jan; 157():114048. PubMed ID: 36463827
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
Kose T; Sharp PA; Latunde-Dada GO
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
